Status:
COMPLETED
A Prospective Randomized Trial on Mycophenolate Mofetil in Risk Penetrating Keratoplasty
Lead Sponsor:
University Hospital Freiburg
Collaborating Sponsors:
Hoffmann-La Roche
Conditions:
Corneal Transplantation
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The purpose of this prospectively randomized multicentre study was to prove the efficacy and safety of mycophenolate mofetil (MMF) to preventing graft rejection and improvement of clear graft survival...
Eligibility Criteria
Inclusion
- Keratoplasty with increased risk for immunologic graft rejection in the abscence of other risk factors for graft failure. (repeat keratoplasty, steroid-response, limbo-keratoplasty, oversized graft.
Exclusion
- Normal risk cases. Herpes-Keratitis. Glaucoma. Limbus stem cell deficiency.
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00411515
Last Update
December 15 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Eye hospital
Freiburg im Breisgau, Germany, 79106